日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry study

肿瘤体积在常见淋巴瘤亚型现代治疗中的预后价值:一项澳大利亚淋巴瘤及相关疾病登记研究

Chung, Eliza; Wang, Luke; Wellard, Cameron; Barraclough, Allison; Campbell, Belinda A; Chong, Geoffrey; Ciaccio, Pietro Di; Gregory, Gareth P; Hapgood, Greg; Johnston, Anna M; Tam, Constantine S; Opat, Stephen; Wood, Erica M; McQuilten, Zoe K; Hawkes, Eliza A

Zanubrutinib for the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies

泽布替尼用于治疗伴有del(17p)和/或TP53 CLL/SLL的患者:临床研究分析

Tam, Constantine S; Anderson, Mary Ann; Šimkovič, Martin; Ghia, Paolo; Flinn, Ian W; Laribi, Kamel; Opat, Stephen; Cull, Gavin; Munir, Talha; Österborg, Anders; Tedeschi, Alessandra; Wang, Megan; Szeto, Andy; Allewelt, Heather; Salmi, Tommi; Li, Jessica; Xu, Linlin; Wu, Kenneth; Vezan, Remus; Shadman, Mazyar; Brown, Jennifer R

Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA

在初治慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者中,Zanubrutinib 与 Bendamustine 和 Rituximab 的疗效比较:SEQUOIA 研究的中位 5 年随访结果

Shadman, Mazyar; Munir, Talha; Robak, Tadeusz; Brown, Jennifer R; Kahl, Brad S; Ghia, Paolo; Giannopoulos, Krzysztof; Šimkovič, Martin; Österborg, Anders; Laurenti, Luca; Walker, Patricia A; Opat, Stephen S; Ciepluch, Hanna; Greil, Richard; Hanna, Merit; Tani, Monica; Trněný, Marek; Brander, Danielle; Flinn, Ian W; Grosicki, Sebastian; Verner, Emma; Tedeschi, Alessandra; de Guibert, Sophie; Tumyan, Gayane; Laribi, Kamel; García-Marco, José A; Li, Jian-Yong; Tian, Tian; Liu, Yu; Korolkiewicz, Roman; Szeto, Andy; Tam, Constantine S; Jurczak, Wojciech

Real-World Data on Lymphoma in Adolescents and Young Adults (AYA)-Report From the Lymphoma and Related Diseases Registry (LaRDR)

青少年和青年淋巴瘤真实世界数据(AYA)——来自淋巴瘤及相关疾病登记处(LaRDR)的报告

Wong, Evangeline Y; Wellard, Cameron; Ng, Jun Yen; Chung, Eliza; McQuilten, Zoe K; Opat, Stephen; Wood, Erica M; Talaulikar, Dipti

Dynamic Profiling of Cell Free Tumour DNA in Aggressive B-Cell Lymphoma From Diagnosis to Transformation at Relapse

从诊断到复发转化,侵袭性B细胞淋巴瘤中游离肿瘤DNA的动态分析

Waltham, Mark; Wong, Jonathan; Polekhina, Galina; Potezny, Tessa; Dorwal, Pranav; Brasacchio, Daniella; Maher, Belinda; Tedjaseputra, Aditya; Gregory, Gareth P; Opat, Stephen; Shortt, Jake

Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study

Polatuzumab vedotin 联合苯达莫司汀和利妥昔单抗或 obinutuzumab 治疗复发/难治性滤泡性淋巴瘤:Ib/II 期研究

Flowers, Christopher R; Matasar, Matthew J; Herrera, Alex F; Hertzberg, Mark; Assouline, Sarit; Demeter, Judit; McMillan, Andrew; Mehta, Amitkumar; Opat, Stephen; Trnňný, Marek; Musick, Lisa; Hirata, Jamie; Yang, Annie; Sehn, Laurie H

Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study

滤泡性淋巴瘤GELF标准在常规诊疗中的影响和实用性:一项澳大利亚淋巴瘤联盟研究

Barraclough, Allison; Agrawal, Shivam; Talaulikar, Dipti; Chong, Geoffrey; Yoo, Edward; Cheah, Chan Y; Franco, Nunzio; Nguyen, Bianca; Mutsando, Howard; Tahir, Fatima; Trotman, Judith; Huang, Jing; Keane, Colm; Lincoln, Mitchel; Cochrane, Tara; Johnston, Anna M; Dickinson, Michael; Opat, Stephen; McQuilten, Zoe K; Wood, Erica M; St George, Gayathri; Hawkes, Eliza A

Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia

了解澳大利亚慢性淋巴细胞白血病 (CLL) 患者的经历、治疗偏好和目标

Fifer, Simon; Godsell, Jenni; Opat, Stephen; Hamad, Nada; Lasica, Masa; Forsyth, Cecily; Morand, Louisa; Smeaton, Erica; Winton, Sharon; Puig, Andrea; McGeachie, Marija

Fostering inclusive science media: Insights from examining the relationship between women's identities and their anticipated engagement with Deep Look YouTube science videos

促进包容性科学媒体:通过研究女性身份与其预期参与 Deep Look YouTube 科学视频之间的关系,获得一些启示

Steinke, Jocelyn; Gilbert, Christine; Opat, Kelsi; Landrum, Asheley R

Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance

澳大利亚淋巴瘤联盟的一项报告显示,在真实世界中,序贯高剂量甲氨蝶呤和阿糖胞苷治疗可改善原发性中枢神经系统淋巴瘤患者的预后。

Tatarczuch, Maciej; Lewis, Katharine Louise; Gunjur, Ashray; Shaw, Briony; Poon, Li Mei; Paul, Erin; Ku, Matthew; Wong, Mark; Ai, Sylvia; Beekman, Ashley; Ciaccio, Pietro R Di; Krigstein, Michael; Wight, Joel; Coombes, Caitlin; Gilbertson, Michael; Tey, Amanda; Shortt, Jake; Nagarajan, Chandramouli; Talaulikar, Dipti; Hamad, Nada; Ratnasingam, Sumita; Ho, Shir-Jing; Cochrane, Tara; Hawkes, Eliza A; Cheah, Chan Y; Opat, Stephen; Gregory, Gareth P